Salmeterol + Fluticasone Inhaler ā Premium Quality Respiratory Medicine Exporter from India
Cordium Pharmaceuticals is a trusted Indian pharmaceutical exporter offering high-quality Salmeterol + Fluticasone Inhalers manufactured in WHO-GMP compliant facilities. We supply premium respiratory medicines to hospitals, pharmacies, distributors, government tenders, and importers worldwide.
Our Salmeterol + Fluticasone Inhaler combines a Long-Acting Beta2 Agonist (LABA) with an Inhaled Corticosteroid (ICS) to provide long-term control of asthma and chronic obstructive pulmonary disease (COPD).
Product Specifications
Product Name: Salmeterol + Fluticasone Inhaler
Dosage Form: Metered Dose Inhaler (MDI) / Dry Powder Inhaler (DPI)
Composition: Salmeterol + Fluticasone Propionate
Therapeutic Category: Anti-Asthmatic / Anti-COPD Medicine
Packaging: As per customer requirement and export standards
Manufacturing Standard: WHO-GMP Certified Facility
Product Introduction
Salmeterol + Fluticasone Inhaler is an effective maintenance treatment for asthma and COPD. Salmeterol relaxes airway muscles for prolonged bronchodilation, while Fluticasone reduces airway inflammation, helping patients breathe more comfortably and reducing exacerbations.
Uses
Long-term treatment of Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Prevention of wheezing
Reduces airway inflammation
Improves breathing capacity
Helps prevent asthma attacks
Maintenance therapy for respiratory diseases
Dosage Information
Use only as prescribed by a physician.
Usually 1ā2 inhalations twice daily, depending on the patient's condition.
Do not exceed the recommended dose.
Rinse the mouth after each use to reduce the risk of oral fungal infection.
Not intended for immediate relief of acute asthma attacks.
Why Choose Cordium Pharmaceuticals?
WHO-GMP quality manufacturing
Reliable global pharmaceutical exporter
Competitive export pricing
Consistent product quality
Custom private labeling and third-party manufacturing
Export documentation support
Timely worldwide delivery
Dedicated customer support
Bulk supply for distributors, hospitals, pharmacies, and government tenders
Export Countries We Serve
We export Salmeterol + Fluticasone Inhalers to:
USA: New York, Los Angeles, Chicago, Houston
UK: London, Birmingham, Manchester, Liverpool
UAE: Dubai, Abu Dhabi, Sharjah
South Africa: Johannesburg, Cape Town, Durban, Pretoria
Singapore
Malaysia: Kuala Lumpur, Johor Bahru, Penang
Kenya: Nairobi, Mombasa, Kisumu
Contact Cordium Pharmaceuticals
Cordium Pharmaceuticals
Export Enquiries:
š Mobile / WhatsApp: +91-9405117673
š§ Email: info@cordiumpharma.com
Cordium Pharmaceuticals is a trusted Indian pharmaceutical exporter offering high-quality Salmeterol + Fluticasone Inhalers manufactured in WHO-GMP compliant facilities. We supply premium respiratory medicines to hospitals, pharmacies, distributors, government tenders, and importers worldwide.
Our Salmeterol + Fluticasone Inhaler combines a Long-Acting Beta2 Agonist (LABA) with an Inhaled Corticosteroid (ICS) to provide long-term control of asthma and chronic obstructive pulmonary disease (COPD).
Product Specifications
Product Name: Salmeterol + Fluticasone Inhaler
Dosage Form: Metered Dose Inhaler (MDI) / Dry Powder Inhaler (DPI)
Composition: Salmeterol + Fluticasone Propionate
Therapeutic Category: Anti-Asthmatic / Anti-COPD Medicine
Packaging: As per customer requirement and export standards
Manufacturing Standard: WHO-GMP Certified Facility
Product Introduction
Salmeterol + Fluticasone Inhaler is an effective maintenance treatment for asthma and COPD. Salmeterol relaxes airway muscles for prolonged bronchodilation, while Fluticasone reduces airway inflammation, helping patients breathe more comfortably and reducing exacerbations.
Uses
Long-term treatment of Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Prevention of wheezing
Reduces airway inflammation
Improves breathing capacity
Helps prevent asthma attacks
Maintenance therapy for respiratory diseases
Dosage Information
Use only as prescribed by a physician.
Usually 1ā2 inhalations twice daily, depending on the patient's condition.
Do not exceed the recommended dose.
Rinse the mouth after each use to reduce the risk of oral fungal infection.
Not intended for immediate relief of acute asthma attacks.
Why Choose Cordium Pharmaceuticals?
WHO-GMP quality manufacturing
Reliable global pharmaceutical exporter
Competitive export pricing
Consistent product quality
Custom private labeling and third-party manufacturing
Export documentation support
Timely worldwide delivery
Dedicated customer support
Bulk supply for distributors, hospitals, pharmacies, and government tenders
Export Countries We Serve
We export Salmeterol + Fluticasone Inhalers to:
USA: New York, Los Angeles, Chicago, Houston
UK: London, Birmingham, Manchester, Liverpool
UAE: Dubai, Abu Dhabi, Sharjah
South Africa: Johannesburg, Cape Town, Durban, Pretoria
Singapore
Malaysia: Kuala Lumpur, Johor Bahru, Penang
Kenya: Nairobi, Mombasa, Kisumu
Contact Cordium Pharmaceuticals
Cordium Pharmaceuticals
Export Enquiries:
š Mobile / WhatsApp: +91-9405117673
š§ Email: info@cordiumpharma.com
Keywords
